z-logo
open-access-imgOpen Access
Individuals With Scleroderma May Have Increased Risk of Sleep-Disordered Breathing
Author(s) -
Brandon Nokes,
Hassan Raza,
Rodrigo CartinCeba,
Phillip J. Lyng,
Lois E. Krahn,
Lewis Wesselius,
Clinton Jokerst,
Sarah B. Umar,
W. Leroy Griffing,
Matthew R. Neville,
Atul Malhotra,
James M. Parish
Publication year - 2019
Publication title -
journal of clinical sleep medicine
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.529
H-Index - 92
eISSN - 1550-9397
pISSN - 1550-9389
DOI - 10.5664/jcsm.8036
Subject(s) - medicine , interstitial lung disease , scleroderma (fungus) , cardiology , pulmonary function testing , pulmonary hypertension , population , prospective cohort study , sleep apnea , connective tissue disease , lung , disease , pathology , autoimmune disease , environmental health , inoculation
Scleroderma is associated with abnormal skin thickening, interstitial lung disease, pulmonary hypertension, and abnormalities of the upper airway. These changes can cause cardiopulmonary complications, potentially including sleep-disordered breathing. The objective of this study is to examine the risk of sleep-disordered breathing in patients with scleroderma.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.
Having issues? You can contact us here
Accelerating Research

Address

John Eccles House
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom